Fundraising Fox

Leon Chen, PhD

Partner at The Column Group

About

Leon Chen is a founder-turned-VC who led KAI Pharmaceuticals to an Amgen acquisition with approved drug Parsabiv and serves as a hands-on interim executive and board chair for technical platform biotechs.

Invests in

BiotechHealthtech

Colleagues at The Column Group